Product Information
FLUOXETINE HCL 60 MG TABLET is a generic product labeled by Endo USA Inc., priced at $0.1870 per EA under NDC 49884046811. Its NADAC has been published 445 times since Feb 14, 2018.
FDA first approved this application on Nov 16, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Fluoxetine market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
60 mg/1
Manufacturer
Endo USA Inc.NDC
49884046811
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
FLUOXETINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA209419FDA Approved
11/16/2017
TE Code
AB
On Market Since
11/16/2017
Pharmacological Classes
Price Statistics
The NADAC for FLUOXETINE HCL 60 MG TABLET has been published 445 times since Feb 14, 2018, and over the history we have for it it has declined 98.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1870 per EA |
|---|---|
| All-time high | $9.3048 (Feb 14, 2018) |
| All-time low | $0.1870 (Aug 19, 2026) |
| 52-week high | $0.4087 |
| 52-week low | $0.1870 |
| Median price | $0.8563 |
| Average price | $1.9743 |
| Largest weekly change | -58.4% (Jul 22, 2020) |
| Weeks tracked | 445 |
| Tracking since | Feb 14, 2018 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of FLUOXETINE HCL 60 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for FLUOXETINE HCL 60 MG TABLET, manufactured by Endo USA Inc., is $0.1870 per EA (NDC 49884046811), effective Aug 19, 2026.
How has the price of FLUOXETINE HCL 60 MG TABLET changed over time?
Over the history we have for it, the NADAC for FLUOXETINE HCL 60 MG TABLET has declined 98.0%. It has been tracked across 445 weekly CMS publications since Feb 14, 2018.
What are the highest and lowest recorded NADAC prices for FLUOXETINE HCL 60 MG TABLET?
Since Feb 14, 2018, the NADAC for FLUOXETINE HCL 60 MG TABLET has ranged from a low of $0.1870 (Aug 19, 2026) to a high of $9.3048 (Feb 14, 2018), with a median of $0.8563 per EA.
Are there cheaper alternatives to FLUOXETINE HCL 60 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as FLUOXETINE HCL 60 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures FLUOXETINE HCL 60 MG TABLET?
FLUOXETINE HCL 60 MG TABLET (NDC 49884046811) is labeled by Endo USA Inc., and CMS classifies it as a generic product.